Elsevier,
Biological Conservation, Volume 292, April 2024
Amphibian rewilding initiatives may provide early indications of ecological health and better contribute to conservation goals, by simultaneously protecting highly endangered species, and promoting ecological stability in these species ecosystems. Authors recommend the rapid (re)introduction of this “forgotten” taxon via the guidelines of trophic rewilding.
Elsevier,
eClinicalMedicine, Volume 70, April 2024
This paper supports SDGs 3 and 15 by examining environmental exposures and risk of inflammatory bowel disease (IBD) in early life in a Danish cohort. The study found that increased agricultural land use was associated with a higher risk of Crohn's disease, while increased biodiversity and green space were associated with a lower risk of Crohn's disease. These findings may have implications for IBD prevention.
Elsevier,
One Earth, Volume 7, 19 April 2024
The paper highlights the interconnectedness of public health crises, such as pandemics, with biodiversity loss and climate change, as increased demand for materials to combat infectious diseases exacerbates environmental pressures, posing a threat to global sustainability and biodiversity.
Elsevier,
The Lancet Planetary Health, Volume 8, April 2024
This Review supports SDGs 3 and 15 by exploring the links between climate change, biodiversity loss, and infectious diseases. The authors focus on the social, political, and financial factors that frame these issues, and suggest that a better understanding of these interactions is needed to drive solutions.
Elsevier,
Neuroscience, Volume 544, 19 April 2024
This study demonstrates that electroacupuncture (EA) improves learning and memory in the 5xFAD mouse model of Alzheimer's disease, likely by enhancing functional connectivity between the hippocampus and neocortex and reducing amyloid-β protein expression and deposition. These findings suggest that EA may positively impact resting-state brain activity and connectivity, contributing to cognitive and motor function improvements in AD.
Elsevier,
Behavioural Brain Research, Volume 463, 12 April 2024
This article discusses the potential therapeutic strategy of enhancing mitophagy through rapamycin treatment to alleviate cognitive impairment in Alzheimer's disease by improving mitochondrial dysfunction and neuronal loss, suggesting a novel mechanism for the neuroprotective effects of rapamycin in AD.
Elsevier,
Frontiers in Neuroendocrinology, Volume 73, April 2024
This review discusses the multifaceted physiological functions of cholecystokinin (CCK), its potential neuroprotective effects in Alzheimer’s and Parkinson’s diseases, and its therapeutic implications, including its impact on memory, neurotransmitters, and neuroprotection mechanisms.
Elsevier,
Brain Research, Volume 1829, 15 April 2024
Despite diagnostic challenges in differentiating lvPPA and nfvPPA, particularly in advanced cases, this study reveals divergent clinical courses and highlights the importance of assessing emotion processing capacity in dementia diagnosis and monitoring. Utilizing spatiotemporal LME modelling, the research provides valuable insights into the dynamic changes in brain atrophy and behavior, underscoring the need for ongoing evaluation of clinical requirements for patients and families over the disease course.
